NCT03025256 2026-04-02Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal DiseaseM.D. Anderson Cancer CenterPhase 1 Recruiting75 enrolled
NCT04447027 2026-01-30Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1 Completed26 enrolled 24 charts